GlobeStar Therapeutics Corporation
GSTC
$0.00
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -887.10K | -1.97M | -1.95M | -1.95M | -1.91M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 25.60K | 30.10K | 29.30K | 33.30K | 34.30K |
| Total Other Non-Cash Items | 143.80K | 1.28M | 1.27M | 1.26M | 1.17M |
| Change in Net Operating Assets | 569.30K | 497.50K | 437.90K | 446.80K | 532.30K |
| Cash from Operations | -148.30K | -168.10K | -209.40K | -205.70K | -171.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 95.30K | 87.90K | 84.20K | 59.40K | 23.70K |
| Total Debt Repaid | -14.00K | -14.50K | -5.50K | -5.50K | -5.50K |
| Issuance of Common Stock | 67.00K | 94.50K | 85.00K | 72.50K | 45.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 38.00K | 73.00K | 108.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 148.30K | 167.90K | 201.70K | 199.40K | 171.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00 | -200.00 | -7.70K | -6.30K | 100.00 |